GLRX and Parkinson disease: Both protein modifications (i.e., S-nitrosylation and S-glutathionylation) have a significant influence on the onset and course of illnesses, particularly neurodegenerative disorders, as shown by instances of increased cell death in Grx defective C. elegans models for PD [59].